After a final risk assessment and consideration of public comment, NIH published its final approval notice for a new state-of-the-art National Biocontainment Laboratory – the National Emerging Infectious Diseases Laboratories (NEIDL). Final State approval processes remain to be completed now. A spokesperson for Boston University Medical Center (BUMC) told the Boston Globe “the rest of the facility probably would not open before the end of this year or early 2014, assuming it obtains all remaining approvals.” The lab is currently partially open, with work limited to BSL-2, on the BUMC campus in Boston, Massachusetts.
